Concepedia

Qingjie Mou

QM

4

Publications

203

Citations

4

H-Index

2012

Active since

Affiliations

Weifang Medical University(Current)

Qingjie Mou is an author at Weifang Medical University specializing in prognostic biomarkers, urology, and molecular diagnostics.

Top concepts

Publications per year

2012–2019

4

Publications

4

MiR-486-5p inhibits IL-22-induced epithelial-mesenchymal transition of breast cancer cell by repressing Dock1

Hongli Li, Qingjie Mou, Peirui Li et al. · Journal of Cancer · 2019 · 77 citations · Full text

<i>MiR‐577</i> suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25

Chonggao Yin, Qingjie Mou, Xinting Pan et al. · Thoracic Cancer · 2018 · 57 citations · Full text

Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21

Zumu Liang, Qingjie Mou, Zhiwei Pan et al. · Medical Oncology · 2019 · 57 citations

, , +7

Predictive value of ankle-brachial index and blood glucose on the outcomes of six-year all-cause mortality and cardiovascular mortality in a Chinese population of type 2 diabetes patients.

Yukun Wang, Qingjie Mou, Di Zhao et al. · PubMed · 2012 · 12 citations

Rows per page

1–4 of 4